Cargando…

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma

WD repeat-containing protein 1 (WDR1) regulates the cofilin 1 (CFL1) activity, promotes cytoskeleton remodeling, and thus, facilitates cell migration and invasion. A previous study reported that autoantibodies against CFL1 and β-actin were useful biomarkers for diagnosing and predicting the prognosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Masaaki, Yajima, Satoshi, Suzuki, Takashi, Oshima, Yoko, Nanami, Tatsuki, Sumazaki, Makoto, Shiratori, Fumiaki, Wang, Hao, Hu, Liubing, Takizawa, Hirotaka, Li, Shu-Yang, Iwadate, Yasuo, Hiwasa, Takaki, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983066/ https://www.ncbi.nlm.nih.gov/pubmed/36875818 http://dx.doi.org/10.3892/mi.2023.71

Ejemplares similares

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer
por: Ito, Masaaki, et al.
Publicado: (2022)

Comparison between a new assay system, Elecsys(®) Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study
por: Suzuki, Takashi, et al.
Publicado: (2022)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction
por: Kubota, Masaaki, et al.
Publicado: (2021)

Diagnostic impact of high serum midkine level in patients with gastric cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Multipanel assay of 17 tumor‐associated antibodies for serological detection of stage 0/I breast cancer
por: Sumazaki, Makoto, et al.
Publicado: (2021)

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)

Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
por: Shiratori, Fumiaki, et al.
Publicado: (2023)

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
por: Li, Shu-Yang, et al.
Publicado: (2021)

Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
por: Ito, Masaaki, et al.
Publicado: (2018)

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease
por: Kubota, Masaaki, et al.
Publicado: (2022)

Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
por: Li, Shu-Yang, et al.
Publicado: (2020)

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
por: Namiki, Toshiki, et al.
Publicado: (2023)

Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
por: Hu, Liubing, et al.
Publicado: (2022)

Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
por: Hiwasa, Takaki, et al.
Publicado: (2021)

Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
por: Sumazaki, Makoto, et al.
Publicado: (2020)

A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
por: Sumazaki, Makoto, et al.
Publicado: (2020)

Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
por: Li, Shu-Yang, et al.
Publicado: (2023)

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas
por: Matsutani, Tomoo, et al.
Publicado: (2012)

Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients
por: Kobayashi, Sohei, et al.
Publicado: (2016)

Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea
por: Katsumata, Yusuke, et al.
Publicado: (2020)

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
por: Adachi-Hayama, Masayo, et al.
Publicado: (2014)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

Inducing multiple antibodies to treat squamous cell esophageal carcinoma
por: Hoshino, Isamu, et al.
Publicado: (2020)

Role of Evaluating MGMT Status and 1p36 Deletion in Radiosurgery-Induced Anaplastic Ependymoma That Rapidly and Completely Resolved by Temozolomide Alone: Case Report and Review of the Literature
por: Hirono, Seiichiro, et al.
Publicado: (2015)

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma
por: Yoshioka, Masaki, et al.
Publicado: (2018)

Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels
por: Arasawa, Takahiro, et al.
Publicado: (2023)

Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy
por: Hama, Satoshi, et al.
Publicado: (2022)

Meta-analysis of anti-Saccharomyces cerevisiae antibodies as diagnostic markers of Behçet’s disease with gastrointestinal involvement
por: Cheng, Linlin, et al.
Publicado: (2020)

Inflammatory Myopathy Associated with Anti-mitochondrial Antibody Presenting Only with Respiratory Failure
por: Fujii, Shintaro, et al.
Publicado: (2021)

Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis
por: Li, Liubing, et al.
Publicado: (2016)

Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer
por: Kobayashi, Sohei, et al.
Publicado: (2021)

Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma
por: Shimada, Hideaki, et al.
Publicado: (2009)

Sum Rules in the CFL Phase of QCD at finite density
por: Manuel, Cristina, et al.
Publicado: (2000)

Matricellular protein Cfl1 regulates cell differentiation
por: Tian, Xiuyun, et al.
Publicado: (2013)

Genetic CFL: Hyperparameter Optimization in Clustered Federated Learning
por: Agrawal, Shaashwat, et al.
Publicado: (2021)

Targeting WDR5: A WINning Anti-Cancer Strategy?
por: Aho, Erin R, et al.
Publicado: (2019)

Elevation of Autoantibody in Patients with Ischemic Stroke
por: YOSHIDA, Yoichi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_svcc3j0jls2ckilucvtumr4mab